Szerző: " Bhatt Deepak L"

Export [RSS feed] RSS 1.0 [RSS2 feed] RSS 2.0
Találatok száma: 4.

Nicholls Stephen J; Pavo Imre; Bhatt Deepak L; Buse John B; Del Prato Stefano; Kahn Steven E; Lincoff A Michael; McGuire Darren K; Miller Debra; Nauck Michael A; Nishiyama Hiroshi; Nissen Steven E; Sattar Naveed; Weerakkody Govinda; Wiese Russell J; Zinman Bernard; Zoungas Sophia; Basile Jan; Davies Melanie J; Giorgino Francesco; Kellerer Monika; Ji Linong; Várkonyi Tamás; Menon Venu; Broder Jonathan C; Herschtal Alan; D'Alessio David; Kollaborációs szervezet: SURPASS-CVOT Investigators; et al.: Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes.
NEW ENGLAND JOURNAL OF MEDICINE, 393 (24). pp. 2409-2420. ISSN 0028-4793 (2025)

Szarek Michael; Steg Ph Gabriel; DiCenso Dina; Bhatt Deepak L; Bittner Vera A; Kollaborációs szervezet: ODYSSEY OUTCOMES Committees and Investigators; Merkely Béla Péter; Ungi Imre; Horváth Iván: Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 12 (11). ISSN 1941-7705 (2019)

Steg Philippe Gabriel; Szarek Michael; Bhatt Deepak L; Bittner Vera A; Brégeault Marie-France; Kollaborációs szervezet: ODYSSEY OUTCOMES Committees and Investigators; Merkely Béla Péter; Ungi Imre; Horváth Iván: Effect of Alirocumab on Mortality After Acute Coronary Syndromes.
CIRCULATION, 140 (2). pp. 103-112. ISSN 0009-7322 (2019)

Roe Matthew T; Li Qian H; Bhatt Deepak L; Bittner Vera A; Diaz Rafael; Kollaborációs szervezet: ODYSSEY OUTCOMES Investigators; Merkely Béla Péter; Ungi Imre; Horváth Iván: Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes.
CIRCULATION, 140 (19). pp. 1578-1589. ISSN 0009-7322 (2019)

A lista elkészítésének dátuma 2025. december 28. 10:57:52 CET.